The forecast for the number of multidrug-resistant tuberculosis cases started on treatment in the UK from 2024 to 2028 suggests a gradual decline. With 42 cases projected in 2024, decreasing to 37 cases by 2028, this reflects a declining trend. The compound annual growth rate (CAGR) indicates an average annual decrease, reflecting ongoing efforts in tackling tuberculosis, though precise figures from prior years cannot be disclosed beyond 2023.

Future trends to watch for:

Continued policy and healthcare interventions aimed at reducing tuberculosis rates.
Potential impact of new treatments or vaccine developments.
Changes in healthcare funding and public health initiatives.